Press release
Acute Gout Flare Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | Novartis, Olatec Therapeutics, Dyve Biosciences, Changchun GeneScience Pharma, Regeneron Pharmaceuticals
To Know in detail about the Acute Gout Flare market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acute Gout Flare Market Forecast
https://www.delveinsight.com/sample-request/acute-gout-flare-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Acute Gout Flare Market Report:
• The Acute Gout Flare market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• The overall occurrence of gout affects 1-4% of the general population. There is a higher susceptibility to gout in men compared to women. In Western countries, the prevalence is approximately 3-6% in men and 1-2% in women.
• Gout results in around 7 million outpatient visits in the United States each year, incurring a cost of almost USD 1 billion.
• Key Acute Gout Flare Companies: Olatec Therapeutics, Dyve Biosciences, Changchun GeneScience Pharma, Regeneron Pharmaceuticals, Novartis, LG Chem, Novartis, Organon and Co, Revive Therapeutics, Ltd., and others
• Key Acute Gout Flare Therapies: Dapansutrile, DYV700, Genakumab for injection, Rilonacept, ACZ885, Tigulixostat, Canakinumab, MK0663, Bucillamine, and others
• The Acute Gout Flare epidemiology based on gender analyzed that Gout is three times more prevalent in males than females
• The Acute Gout Flare market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Acute Gout Flare pipeline products will significantly revolutionize the Acute Gout Flare market dynamics.
Acute Gout Flare Overview
An acute gout flare refers to a sudden and intense episode of pain, swelling, redness, and tenderness in a joint caused by the inflammatory response to the crystallization of uric acid in the joint. Gout is a type of arthritis characterized by elevated levels of uric acid in the blood, leading to the formation of urate crystals in the joints.
Get a Free sample for the Acute Gout Flare Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/acute-gout-flare-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Acute Gout Flare Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Acute Gout Flare Epidemiology Segmentation:
The Acute Gout Flare market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Acute Gout Flare
• Prevalent Cases of Acute Gout Flare by severity
• Gender-specific Prevalence of Acute Gout Flare
• Diagnosed Cases of Episodic and Chronic Acute Gout Flare
Download the report to understand which factors are driving Acute Gout Flare epidemiology trends @ Acute Gout Flare Epidemiology Forecast
https://www.delveinsight.com/sample-request/acute-gout-flare-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Acute Gout Flare Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Acute Gout Flare market or expected to get launched during the study period. The analysis covers Acute Gout Flare market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Acute Gout Flare Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Acute Gout Flare Therapies and Key Companies
• Dapansutrile: Olatec Therapeutics
• DYV700: Dyve Biosciences
• Genakumab for injection: Changchun GeneScience Pharma
• Rilonacept: Regeneron Pharmaceuticals
• ACZ885: Novartis
• Tigulixostat: LG Chem
• Canakinumab: Novartis
• MK0663: Organon and Co
• Bucillamine: Revive Therapeutics, Ltd.
Discover more about therapies set to grab major Acute Gout Flare market share @ Acute Gout Flare Treatment Landscape
https://www.delveinsight.com/sample-request/acute-gout-flare-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Scope of the Acute Gout Flare Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Acute Gout Flare Companies: Olatec Therapeutics, Dyve Biosciences, Changchun GeneScience Pharma, Regeneron Pharmaceuticals, Novartis, LG Chem, Novartis, Organon and Co, Revive Therapeutics, Ltd., and others
• Key Acute Gout Flare Therapies: Dapansutrile, DYV700, Genakumab for injection, Rilonacept, ACZ885, Tigulixostat, Canakinumab, MK0663, Bucillamine, and others
• Acute Gout Flare Therapeutic Assessment: Acute Gout Flare current marketed and Acute Gout Flare emerging therapies
• Acute Gout Flare Market Dynamics: Acute Gout Flare market drivers and Acute Gout Flare market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Acute Gout Flare Unmet Needs, KOL's views, Analyst's views, Acute Gout Flare Market Access and Reimbursement
To know more about Acute Gout Flare companies working in the treatment market, visit @ Acute Gout Flare Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/acute-gout-flare-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Acute Gout Flare Market Report Introduction
2. Executive Summary for Acute Gout Flare
3. SWOT analysis of Acute Gout Flare
4. Acute Gout Flare Patient Share (%) Overview at a Glance
5. Acute Gout Flare Market Overview at a Glance
6. Acute Gout Flare Disease Background and Overview
7. Acute Gout Flare Epidemiology and Patient Population
8. Country-Specific Patient Population of Acute Gout Flare
9. Acute Gout Flare Current Treatment and Medical Practices
10. Acute Gout Flare Unmet Needs
11. Acute Gout Flare Emerging Therapies
12. Acute Gout Flare Market Outlook
13. Country-Wise Acute Gout Flare Market Analysis (2019-2032)
14. Acute Gout Flare Market Access and Reimbursement of Therapies
15. Acute Gout Flare Market Drivers
16. Acute Gout Flare Market Barriers
17. Acute Gout Flare Appendix
18. Acute Gout Flare Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Acute Gout Flare Epidemiology https://www.delveinsight.com/report-store/acute-gout-flare-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Acute Gout Flare Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Acute Gout Flare epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Resorbable Vascular Scaffold Market
https://www.delveinsight.com/report-store/resorbable-vascular-scaffolds-market
"DelveInsight's 'Resorbable Vascular Scaffolds Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Resorbable Vascular Scaffolds and the historical and forecasted Resorbable Vascular Scaffolds market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Vascular Stents Market
https://www.delveinsight.com/report-store/vascular-stents-market
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2028 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population.
Bladder Scanners Market
https://www.delveinsight.com/report-store/bladder-scanners-market
"DelveInsight's 'Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Vein Illumination Devices Market
https://www.delveinsight.com/report-store/vein-illumination-devices-market
"DelveInsight's 'Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Ventilator Market
https://www.delveinsight.com/report-store/ventilators-market
Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to launch of advanced devices and increasing prevalence of respiratory diseases such as COPD.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
Contact No.: +91-9650213330
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acute Gout Flare Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | Novartis, Olatec Therapeutics, Dyve Biosciences, Changchun GeneScience Pharma, Regeneron Pharmaceuticals here
News-ID: 3358809 • Views: …
More Releases from DelveInsight Business Research
HPK1 Inhibitors Market Outlook 2034: Comprehensive 7MM Forecast, Emerging Pipeli …
DelveInsight has released its latest report, "HPK1 Inhibitor Competitive Landscape And Market Forecast - 2034," delivering an in-depth analysis of the rapidly evolving HPK1 inhibitor market. The report offers a comprehensive overview of the epidemiology, drug uptake, treatment landscape, competitive intelligence, and market dynamics shaping the outlook of HPK1 inhibitors across the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan.
To know more about the HPK1 Inhibitor…
Hypersomnia Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Prog …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hypersomnia pipeline constitutes 3+ key companies continuously working towards developing 4+ Hypersomnia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Hypersomnia Pipeline Insight, 2026" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Hypersomnia Market.
The Hypersomnia Pipeline report embraces in-depth…
Diabetic Kidney Disease Pipeline 2026: Therapies Under Investigation, Clinical T …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Diabetic Kidney Disease pipeline constitutes key companies continuously working towards developing Diabetic Kidney Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Diabetic Kidney Disease Pipeline Insight, 2026" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Diabetic Kidney Disease Market.
…
Pompe Disease Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and K …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, Pompe Disease pipeline constitutes 15+ key companies continuously working towards developing 20+ Pompe Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Pompe Disease Pipeline Insight, 2026" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Pompe Disease Market.
The Pompe Disease…
More Releases for Gout
Chronic Gout Market Trends, Therapeutics, and Growth Opportunities
Chronic gout is a progressive form of arthritis characterized by elevated uric acid levels, leading to severe joint pain, inflammation, and long-term joint damage. This condition affects millions worldwide, often resulting in impaired mobility and reduced quality of life. With rising prevalence due to lifestyle changes, aging populations, and dietary habits, the Chronic Gout market is witnessing a surge in demand for advanced therapeutics, early diagnostics, and patient management solutions.
Download…
Chronic Gout Market Massive Growth opportunity Ahead
Introduction
Chronic gout is a form of arthritis characterized by recurrent attacks of severe pain, swelling, and inflammation in the joints, often due to the accumulation of uric acid crystals. This condition typically affects the big toe but can also impact other joints, including the knees, elbows, and wrists. Uric acid, a by-product of purine metabolism, accumulates in the body due to overproduction or underexcretion by the kidneys, leading to hyperuricemia…
Gout Market Innovations in Pain Management and Treatment
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Gout Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many…
Gout Therapeutics Market Analysis By Drug Class (Nonsteroidal Anti-inflammatory …
Report Summary
The global gout therapeutics market was valued at USD 2.78 Billion in 2021 and is expected to grow at a CAGR of 13.7% during the forecast period 2023-2032.
Gout Therapeutics Market Introduction
The deposition of monosodium crystals (MSU) into the distal joints and peripheral tissues results in gout, an inflammatory arthritic disease. Gout is a typical type of painful inflammatory arthritis. One joint is typically affected at a time (often…
Global Gout Drugs Market Analysis (2020-2025)
Global Info Research offers a latest published report on Gout Drugs Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Gout Drugs Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/reports/371311/gout-drugs
Market…
Gout Therapeutics Market Emerging Trends And Forecast By 2025
Global Gout Therapeutics Market: Snapshot
The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications.
Patients with multiple episodes of severe gout attacks every year or with…
